Using CANTAB to study the relationships between executive function, eating behavior and preoperative
PhD candidate Gro Walø-Syversen of Oslo University Hospital, shared the role that CANTAB played in her latest publication: Executive Function, Eating Behavior, and Preoperative Weight Loss in Bariatric Surgery Candidates: An Observational Study.
At the virtual AAIC 2020 conference Dr Francesca Cormack shared her research, focusing on automatic speech recognition for verbal cognitive testing.
At the virtual AAIC 2020 conference Dr Elizabeth Baker presented data on the successful delivery of CANTABTM assessments across diverse health systems and ages: 10 – 90 years old.
The study captures normative performance across the lifespan to support a cognitive screening tool for characterising a range of neuropsychological disorders in clinics across India.
The power of remote assessments is the flexibility in when and where they can be administered. However, with this increased flexibility comes a responsibility to collect data at a frequency that is meaningful but not burdensome for the patient. This article will cover how to navigate this tricky process and strike the balance.
Older adults shoulder a disproportionate burden of chronic diseases and consumption of prescription drugs. Nevertheless, older adults, especially those aged over 75 years, are chronically under-represented in clinical trials. In this two part series, Dr Kiri Granger explores the risks of under-presentation and outlines guidance for including older adults in clinical trials.
Read on for session two: key design considerations when including elderly patients in clinical trials, with a focus on cognitive assessment.
Older adults are consistently under-represented in clinical trials, even though they take more prescription medications than any other group. In this two part series, Dr Kiri Granger will explore this under-presentation and outline practical considerations for including older adults in clinical trials.
Read on for session one: the importance of addressing the evidence-practice gap.
Examination of the neural basis of psychotic-like experiences in adolescence during processing of em
We caught up with Dr Evan Papanastasiou from King's College London to find out why he chose CANTAB to examine the neural basis of psychotic-like experiences in adolescence during processing of emotional faces.
We caught up with Lydia Devenney from Letterkenny Institute of Technology to find out why she chose CANTAB to assist her research into investigating attention, memory functioning, and mood in a natural setting with real‐life alcohol consumption levels.
What is the impact of stress and environment on executive function and motivation for primary school
We caught up with Toby Bartle, Registered Psychologist and PhD Candidate at James Cook University, to find out why he chose CANTAB when looking at the impact of stress and environment on executive function and motivation for primary school children.
We caught up with University of Ulster researcher, Kyle Wallace, to find out why he chose CANTAB to investigate the links between cognitive function, hydration status and martial arts.
Following steady improvements in survival rates, there is a growing interest in establishing the long-term side effects of cancer treatments. This includes a need for a better understanding of the cognitive safety profile of these interventions, particularly in children and adolescents. In this article, we demonstrate that CANTAB computerised assessments offer a sensitive and practical solution for assessing cognitive function in oncology trials.
Dr Thomas Johansen from the Norwegian National Advisory Unit on Occupational Rehabilitation talked us through why he chose CANTAB to investgate whether improving cognitive function during occupational rehabilitation improves return to work.
Dr Seán Haldane is a Consultant Neuropsychologist and expert witness who provides reports for defence lawyers, the Crown Prosecution Service and the police. We caught up with Dr Haldane to discuss how CANTAB Insight is integral to his work.
We presented a novel, predictive model of functional decline at CTAD 2018. The model suggests that CANTAB PAL and SWM provide essential screening information when recruiting patients with amnestic mild cognitive impairment into Alzheimer’s disease clinical trials.
We caught up with University of Calgary Postdoctoral Research Fellows, Dr Matiram Pun and Dr Veronica Guadagni, to discuss the role of CANTAB in their recent research paper on how different exposures to high altitude affect cognitive function.
We caught up with Shinwon Park at Ewha Womens University to discuss their experiences of updating their longitudinal studies from tablet-only CANTAB Eclipse to the cloud-based CANTAB Connect Research platform.
PhD researcher, Rosalyn Hithersay, spoke to us about her recent publication on which cognitive tests are most sensitive to the early stages of dementia in Down syndrome.
We are very pleased to announce a planned new software product to assess mental health and wellbeing at work, CANTAB BrainHealth™.
With rising life-expectancy, the number of cases of dementia and related disorders is increasing. In attempts to tackle the pandemic, treatment trials are moving earlier in the disease process. CANTAB offers a battery of tests specially targeted at assessing cognition in early Alzheimer’s disease (AD), and the associated effects on cognition with drug action.
Published in Drug Discovery Today, our keynote review outlines the rationale, study design, and methods for cognitive safety assessment during clinical drug development.
Mood disorders affect 5-10% of the adult population in a given year. The most common mood disorders are major depressive disorder, dysthymia, and bipolar disorder. Here we explore the six CANTAB tests for objectively measuring cognitive function in depression.
Cognition is essential for everyday functioning - here's why.